Abcam PLC
LSE:ABC

Watchlist Manager
Abcam PLC Logo
Abcam PLC
LSE:ABC
Watchlist
Price: 1 226 GBX 11.15% Market Closed
Market Cap: 2.8B GBX

Relative Value

ABC price has not been updated for more than 1 month. This may indicate that the stock has been delisted.

There is not enough data to reliably calculate the relative value of ABC.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ABC Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
8
Median 5Y
8
Industry
8.2
Forward
7
vs History
vs Industry
Median 3Y
412.7
Median 5Y
412.7
Industry
24.2
Forward
40.5
vs History
vs Industry
Median 3Y
22.3
Median 5Y
22.3
Industry
23
vs History
vs Industry
Median 3Y
536.5
Median 5Y
536.5
Industry
25.5
vs History
vs Industry
Median 3Y
3.9
Median 5Y
3.9
Industry
3.3
vs History
vs Industry
Median 3Y
8.3
Median 5Y
8.3
Industry
8.6
Forward
7.3
vs History
vs Industry
Median 3Y
11.4
Median 5Y
11.4
Industry
10.5
vs History
vs Industry
Median 3Y
25.8
Median 5Y
25.8
Industry
6.1
Forward
23
vs History
vs Industry
Median 3Y
95.5
Median 5Y
95.5
Industry
6.6
Forward
36.2
vs History
vs Industry
Median 3Y
23.1
Median 5Y
23.1
Industry
8.8
vs History
vs Industry
Median 3Y
111.2
Median 5Y
111.2
Industry
6.8
vs History
vs Industry
Median 3Y
3.2
Median 5Y
3.2
Industry
5.7

Multiples Across Competitors

ABC Competitors Multiples
Abcam PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
Abcam PLC
LSE:ABC
2.8B GBP 8 412.7 25.8 95.5
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 170 980.7 -162 409.6 -197 217.1 -194 966.6
US
Abbvie Inc
NYSE:ABBV
379.8B USD 6.4 161.8 15.8 22.4
US
Amgen Inc
NASDAQ:AMGN
176.7B USD 4.9 25.2 18.2 18.2
US
Gilead Sciences Inc
NASDAQ:GILD
153.3B USD 5.3 18.9 12.7 12.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
112.7B USD 9.6 30.7 22.5 23.5
US
Epizyme Inc
F:EPE
94.1B EUR 2 061.7 -526.1 -572.9 -557.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.6B USD 5.4 16.9 16.1 18.3
AU
CSL Ltd
ASX:CSL
85B AUD 3.7 19 12.8 16
NL
argenx SE
XBRU:ARGX
43.3B EUR 13.9 32.8 56.4 58
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.8B USD 14.9 1 097.1 147.8 179.3
P/S Multiple
Revenue Growth P/S to Growth
UK
Abcam PLC
LSE:ABC
Average P/S: 3 106 646.8
8
3%
2.7
FR
Pharnext SCA
OTC:PNEXF
34 170 980.7
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6.4
9%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.9
5%
1
US
Gilead Sciences Inc
NASDAQ:GILD
5.3
4%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
9.6
10%
1
US
E
Epizyme Inc
F:EPE
2 061.7
N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.4
6%
0.9
AU
CSL Ltd
ASX:CSL
3.7
5%
0.7
NL
argenx SE
XBRU:ARGX
13.9
49%
0.3
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
14.9
46%
0.3
P/E Multiple
Earnings Growth PEG
UK
Abcam PLC
LSE:ABC
Average P/E: 201.7
412.7
85%
4.9
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -162 409.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
161.8
89%
1.8
US
Amgen Inc
NASDAQ:AMGN
25.2
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
18.9
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
30.7
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -526.1 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.9
10%
1.7
AU
CSL Ltd
ASX:CSL
19
11%
1.7
NL
argenx SE
XBRU:ARGX
32.8
40%
0.8
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 097.1
N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
UK
Abcam PLC
LSE:ABC
Average EV/EBITDA: 36.5
25.8
20%
1.3
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -197 217.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.8
14%
1.1
US
Amgen Inc
NASDAQ:AMGN
18.2
11%
1.7
US
Gilead Sciences Inc
NASDAQ:GILD
12.7
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.5
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -572.9 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.1
11%
1.5
AU
CSL Ltd
ASX:CSL
12.8
8%
1.6
NL
argenx SE
XBRU:ARGX
56.4
810%
0.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
147.8
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
UK
Abcam PLC
LSE:ABC
Average EV/EBIT: 49.3
95.5
44%
2.2
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 966.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.4
30%
0.7
US
Amgen Inc
NASDAQ:AMGN
18.2
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.7
12%
1.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.5
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -557.6 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.3
13%
1.4
AU
CSL Ltd
ASX:CSL
16
11%
1.5
NL
argenx SE
XBRU:ARGX
58
N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
179.3
N/A N/A